BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4
178 results:

  • 1. Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?
    Schachenhofer J; Gruber VE; Fehrer SV; Haider C; Glatter S; Liszewska E; Höftberger R; Aronica E; Rössler K; Jaworski J; Scholl T; Feucht M
    Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12974. PubMed ID: 38562027
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms.
    Cowzer D; Shah RH; Chou JF; Kundra R; Punn S; Fiedler L; DeMore A; Capanu M; Berger MF; Reidy-Lagunes D; Raj N
    Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38252063
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
    Pelosi G; Melocchi V; Dama E; Hofman P; De Luca M; Albini A; Gemelli M; Ricotta R; Papotti M; La Rosa S; Uccella S; Harari S; Sonzogni A; Asiedu MK; Wigle DA; Bianchi F
    Exp Mol Pathol; 2024 Feb; 135():104882. PubMed ID: 38237798
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A study on molecular mechanism of Xihuang pill in the treatment of glioblastoma based on network pharmacology and validation in vitro and in vivo.
    Xu HB; Chen XZ; Zhu SY; Xue F; Zhang YB
    J Ethnopharmacol; 2024 Apr; 323():117675. PubMed ID: 38159819
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.
    Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B
    Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
    Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
    Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. "Oncocytoid Renal cell Carcinomas After Neuroblastoma" Represent TSC -mutated Eosinophilic Solid and Cystic Renal cell Carcinomas : Association With Prior Childhood Malignancy and Multifocality With Therapeutic Implications.
    Argani P; Medeiros LJ; Matoso A; Baraban E; Lotan T; Pawel BR; McKenney JK; Mehra R; Falzarano SM; Pallavajjalla A; Lin MT; Patel S; Rawwas J; Bendel AE; Gagan J; Palsgrove DN
    Am J Surg Pathol; 2023 Dec; 47(12):1335-1348. PubMed ID: 37522346
    [TBL] [Abstract] [Full Text] [Related]  

  • 8.
    Xie J; Yang MR; Hu X; Hong ZS; Bai YY; Sheng J; Tian Y; Shi CY
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511135
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
    Navale P; Chatterjee D; Itani M; Trikalinos NA
    Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine tumors and Metastases.
    Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
    Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms.
    Liu M; Li N; Tang H; Chen L; Liu X; Wang Y; Lin Y; Luo Y; Wei S; Wen W; Chen M; Wang J; Zhang N; Chen J
    Oncologist; 2023 Sep; 28(9):e723-e736. PubMed ID: 37086484
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data.
    Boilève A; Faron M; Fodil-Cherif S; Bayle A; Lamartina L; Planchard D; Tselikas L; Kanaan C; Scoazec JY; Ducreux M; Italiano A; Baudin E; Hadoux J
    Eur J Cancer; 2023 Jun; 186():122-132. PubMed ID: 37062210
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A Clinicopathologic and Molecular Characterization of Uterine Sarcomas Classified as Malignant PEComa.
    Anderson WJ; Dong F; Fletcher CDM; Hirsch MS; Nucci MR
    Am J Surg Pathol; 2023 May; 47(5):535-546. PubMed ID: 36856023
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.
    Umetsu SE; Kakar S; Basturk O; Kim GE; Chatterjee D; Wen KW; Hale G; Shafizadeh N; Cho SJ; Whitman J; Gill RM; Jones KD; Navale P; Bergsland E; Klimstra D; Joseph NM
    Mod Pathol; 2023 Mar; 36(3):100065. PubMed ID: 36788102
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Primary Cutaneous Malignant Perivascular Epithelioid cell tumor Mimicking Undifferentiated Pleomorphic Sarcoma: A Report of a Rare Entity.
    Neumann NM; Cornelia Ding CK; Borgen A; Corvera CU; North JP; Qorbani A; Horvai AE
    Am J Dermatopathol; 2022 Oct; 44(10):768-773. PubMed ID: 36122336
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Tuberous sclerosis complex: diagnosis and current treatment].
    Cerisola A; Cibils L; Chaibún ME; Pedemonte V; Rosas M
    Medicina (B Aires); 2022 Aug; 82 Suppl 3():71-75. PubMed ID: 36054862
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. germline genetic biomarkers to stratify patients for personalized radiation treatment.
    Deichaite I; Hopper A; Krockenberger L; Sears TJ; Sutton L; Ray X; Sharabi A; Navon A; Sanghvi P; Carter H; Moiseenko V
    J Transl Med; 2022 Aug; 20(1):360. PubMed ID: 35962345
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. STAT3 suppresses the AMPKα/ULK1-dependent induction of autophagy in glioblastoma cells.
    Bhattacharya S; Yin J; Yang C; Wang Y; Sims M; Pfeffer LM; Chaum E
    J Cell Mol Med; 2022 Jul; 26(14):3873-3890. PubMed ID: 35670018
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Subependymal Giant cell Astrocytoma with Tuberous Sclerosis Complex(TSC-SEGA)].
    Ichikawa T; Niida Y
    No Shinkei Geka; 2022 Jan; 50(1):111-121. PubMed ID: 35169091
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. tsc2 somatic mosaic mutation, including extra-tumor tissue, may be the developmental cause of solitary subependymal giant cell astrocytoma.
    Sasaki T; Uda T; Kuki I; Kunihiro N; Okazaki S; Niida Y; Goto T
    Childs Nerv Syst; 2022 Jan; 38(1):77-83. PubMed ID: 34741623
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.